Recognition of Dysantic

BV Science is proud to announce that Hungarian Innovation Society awarded an innovation grand prize diploma our Dysantic. This [...]

BV Science on continuous expansion

Besides our operation in Saint Louis, USA, we are adding more production and logistic capacity [...]

Vetanco USA, Inc. welcomes Jeffrey W. Hall, Ph.D. as our new Research and Development Director

Jeffrey W. Hall will be our Research and Development Director in the USA directly reporting to Dr. Sherry [...]

Sherry Layton, closing keynote at the 3rd edition of the Animal Microbiome Congress Europe

Sherry Layton, Ph.D., Chief Scientific Officer for BV Science will give the Closing Keynote presentation at the [...]

Argentine Company looks to license a vaccine developed by researchers of Universidad de Concepcion, Chile

Representatives of Vetanco met with university authorities to discuss a license contract for a recombinant [...]

Maria (Arendt) Dashek, MS, DVM, PhD, has joined BV Science, Inc. as Technical Manager

We are very happy to welcome Maria to our company here in the US as we [...]

BV Science appoints John Dickerson and Charles Delap as Sales Representative

BV Science has announced that John Dickerson has joined the company as a representative for natural health solutions. [...]

INTA researchers won the International Inventors Award and the Silver Medal at the WIPO Exhibition in Geneva

The project, chosen as “The Best Patent in Latin America”, is registered in the National [...]

BV Science at IPPE 2019

BV Science, the joint business unit of Vetanco S.A. and Dr. Bata Ltd., will participate [...]

Vetanco and Dr. Bata Ltd. presented Rumino Zyme® to producers

BV Science, a global business unit created by Vetanco and Dr. Bata Ltd., presented Rumino [...]